October 24, 2014 / 1:32 PM / in 3 years

BUZZ-U.S. Stocks on the Move-Ebola-related stocks, Amazon, Ford

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)

U.S. stock index futures fell on Friday, putting the S&P 500 on track to trim its weekly advance, following disappointing earnings from Amazon and as the first diagnosed case of Ebola in New York City raised concerns about the spread of the virus: Dow Jones industrial average futures were up 0.05 percent at 16,621, S&P 500 futures were up 0.04 percent at 1,946.75 and Nasdaq 100 futures were up 0.08 percent at 4,008.5.

** TEKMIRA PHARMACEUTICALS CORP, Thursday close $19.82, +2.93 pct premarket

** ALPHA PRO TECH LTD, Thursday close $4.6, +12.39 pct premarket

** LAKELAND INDUSTRIES INC, Thursday close $15.26, -3.34 pct premarket

** CHIMERIX INC, Thursday close $32.06, +1.06 pct premarket

** VERSAR INC, Thursday close $3.28, +6.10 pct premarket

Shares of Ebola-related medical equipment makers and drugmakers rose after diagnosis of the first Ebola patient in New York. A doctor, who worked in West Africa with Ebola patients tested positive for the virus, becoming the fourth person diagnosed with the disease in the United States and the first in its largest city.

** AMAZON.COM INC, Thursday close $313.18, -9.06 pct premarket

At least 20 brokerages cut their price targets on the e-commerce giant’s stock, while Cowen and Co downgraded it to “market perform” from “outperform”.

“If the stock continues to get hit, we could even end up in a situation with activists calling for significant changes at Amazon,” Macquarie Equities Research analysts wrote in a note.

Up to Thursday’s close, the stock had fallen about 21 percent this year.

Third quarter profit and revenue, as well as net sales forecast for the fourth quarter - the crucial holiday season - missed average analyst estimates.

** MICROSOFT CORP, Thursday close $45.02, +4.04 pct premarket

At least three brokerages raised their price targets on the world’s largest software company’s shares by $5-$55. The stock - up 20 percent this year to Thursday’s close - has a median price target of $50.

“(CEO Satya) Nadella is helping shift Microsoft’s strategy toward the cloud, mobile, and subscription services, and while this transition will be not be an overnight success, we saw further signs of success in the September quarter, which is key for investors digesting results this morning,” FBR Capital Markets analysts said.

The company reported higher-than-expected first quarter revenue, helped by stronger sales of its phones, Surface tablets and cloud-computing products for companies.

** FORD MOTOR CO, Thursday close $14.4, +0.14 pct premarket

The auto maker’s third-quarter earnings beat Wall Street expectations on a strong showing in North America and China even as revenue fell due to the cost of introducing the F-150 pickup truck.

** PROCTER & GAMBLE CO, Thursday close $83.23, +2.35 pct premarket

The consumer goods giant said it would exit its Duracell battery business, likely through a splitoff into a separate company, as it looks to focus on faster-growing brands. .

The company, which earlier this month completed a management reshuffle as part of plans to revive sagging sales growth and win back market share, said it forecast a stronger dollar this quarter.

For a graphic on Procter & Gamble, Colgate-Palmolive and Kimberly Clark, click (link.reuters.com/syh33w)

** COLGATE-PALMOLIVE CO, Thursday close $65.05, -1.61

The toothpaste maker reported a 17 percent drop in third-quarter profit and lowered its full-year earnings forecast, hurt by weak demand in Brazil and China and a stronger U.S. dollar.

Third quarter profit met forecasts while sales missed the average analyst estimate. Colgate said it expected gross margin for the year to be flat, citing a hit from stronger dollar. The company gets about 82 percent of sales from outside North America.

For a graphic on Procter & Gamble, Colgate-Palmolive and Kimberly Clark, click here link.reuters.com/syh33w

** UNITED PARCEL SERVICE INC, Thursday close $100.48, +2.16 pct premarket

** FEDEX CORP, Thursday close $162.5, +0.37 pct premarket

Determined not to repeat a holiday season that left millions of packages delivered too late and customers seething, United Parcel and FedEx are investing heavily in new infrastructure - but the continued dynamic growth of e-commerce will test those efforts.

** PFIZER INC, Thursday close $28.6, +1.08 pct premarket

The U.S. drugmaker is to continue buying back stock, with the board authorizing a new $11 billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca Plc.

Separately, a U.S. district court ruled in favor of the company in a patent lawsuit it filed against Mylan Inc, alleging patent infringement on its cancer drug, Sutent, Pfizer said on Thursday.

** GRUBHUB INC, Thursday close $37.19, -2.39 pct premarket

Brokerages revised price targets and shareholders sold shares after the company reported third quarter results.

Sources said 3 million shares were sold at $36.75 - a 1.1 percent discount to Thursday’s $37.19 closing price - by an unidentified seller. The company had reported a more than five-fold jump in quarterly profit as more consumers used its online service to order meals.

Goldman Sachs analyst Heath Terry said the company was well positioned to take share of the $77 billion takeout and delivery market in the United States, but cut his target to $42 from $44, “to reflect multiple compression across the sector.”

** ARIAD PHARMACEUTICALS INC, Thursday close $5.71, +1.40 pct premarket

European regulators recommended continued use of Ariad’s cancer drug Iclusig in its already approved indications to treat certain kinds of leukaemia.

** GIGAMON INC, Thursday close $11.59, +14.75 pct premarket

The network traffic management software maker reported better-than-expected third quarter revenue.

** PANDORA MEDIA INC, Thursday close $23.12, -10.47 pct premarket

At least eight brokerages cut their price targets by as much as $7 to as low as $26 on the operator of the leading Internet radio service’s stock, which has a median price target of $32.

The company had reported a lower-than-expected increase in listeners in the third quarter.

** BJ‘S RESTAURANTS INC, Thursday close $33.2, +12.95 pct premarket

At least six brokerages, including Morgan Stanley and Jefferies, raised their price targets on the restaurant chain operator’s stock.

The casual dining restaurant operator on Thursday said third quarter comparable restaurant sales grew 0.3 percent - the first increase after falling four quarters. Sales were driven by a 0.7 percent increase in guest traffic, which more than offset a lower average check.

** LEAR CORP, Thursday close $85.56, +3.42 pct premarket

The maker of auto seats and electrical power systems reported a better-than-expected rise in quarterly profit and raised its 2014 earnings forecast, reflecting robust vehicle production in North America and Europe.

** KLA-TENCOR CORP, Thursday close $71, +7.77 pct premarket

At least four brokerages raise their price targets on the chip and wafer maker’s stock after the company reported better-than-expected quarterly revenue and increased its share repurchase program.

** VITAE PHARMACEUTICALS INC, Thursday close $8.65, +36.30 pct premarket

The biotechnology company said on Thursday its experimental drug to treat Alzheimer’s disease was found safe and well-tolerated across all dose levels tested in early-stage trials.

** QIWI PLC, Thursday close $30.29, -4.32 pct premarket

Goldman Sachs cut its rating on the payment processor’s stock to “sell” from “buy”, citing revenue growth and compliance risk. “We see risks to growth in the financial services, e-commerce and money remittance businesses,” Goldman Sachs analysts wrote in a note.

** NPS PHARMACEUTICALS INC, Thursday close $29.08, -5.36 pct premarket

The pharma company said the U.S. Food and Drug Administration had extended the review date for its hormone replacement therapy by three months to provide time for a full review of a “major amendment.”

** LOCKHEED MARTIN CORP, Thursday close $180.67, +0.52 pct premarket

The aerospace company and U.S. defense officials have reached an agreement on the terms of a contract worth about $4 billion for an eighth batch of 43 F-35 fighter jets, sources familiar with the deal said on Thursday.

** EDWARDS LIFESCIENCES CORP, Thursday close $105.19, +6.97 pct premarket

The medical device maker said its quarterly net earnings rose 23 percent on strong sales of heart valves, prompting the company to raise its full year earnings forecast.

** JUNIPER NETWORKS INC, Thursday close $20.32, -3.44 pct premarket

The network gear maker forecast weaker-than-expected profit and revenue for the current quarter as telecom operators, its main customers, postpone spending until the dust settles on several big mergers.

** FLOTEK INDUSTRIES INC, Thursday close $23.68, +5.36 pct premarket

The specialty chemicals and drilling equipment distributor reported a better-than-expected third quarter profit, helped by higher sales in its energy chemical technologies business, which provides chemical products for drilling and cementing wells.

** SYNAPTICS INC, Thursday close $73.27, -10.86 pct premarket

The touchscreen chip maker reported lower-than-expected first quarter revenue and adjusted profit, hurt by weak demand from smartphone makers, sending its shares down 8.5 percent in extended trading. (Compiled by Shailaja Sharma in Bangalore; Editing by Joyjeet Das)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below